Science and Research IGM Biosciences slides by 66% on discontinued drug development and lay offs The biotech company has put the halt on 2 therapeutics used to treat arthritis, lupus and myasthenia gravis Rowan DunneJanuary 10, 2025
Medical and Pharmaceutical Scottish study finds biomarker blood biopsy testing can reduce lung cancer fatalities by 40% It was completed by the University of St Andrews and published in the PLOS One journal on Wednesday Rowan DunneJanuary 9, 2025
AI and Autonomy Predictive Oncology shares rise 71% as takeover by Renovaro is announced Both companies are focused on AI-powered drug discovery Rowan DunneJanuary 6, 2025
Medical and Pharmaceutical Russia develops mRNA cancer vaccine for citizens, skepticism lingers An absence of data has rendered the announcement questionable Rowan DunneJanuary 2, 2025
Cannabis Morocco launches nation’s first cannabinoid drug for epilepsy treatment Morocco harvested 294 metric tons of legal cannabis last year Rowan DunneDecember 20, 2024
Medical and Pharmaceutical Krystal Biotech reports success with inhalable lung cancer drug in early-stage trial KB707 demonstrated a 27% objective response rate and 73% disease control rate Rowan DunneDecember 19, 2024
Medical and Pharmaceutical Scientists develop scan technique to light up aggressive lung cancer ‘like a Christmas tree’ More treatment innovation just in time for the holidays Rowan DunneDecember 18, 2024
Medical and Pharmaceutical Cizzle Biotechnology expands lung cancer blood biopsy test distribution into Caribbean This UK oncology company was spun out from the University of York's Department of Biology Rowan DunneDecember 16, 2024
Sleep Fraser Health uses sleep tech to help safeguard long-term care residents The BC public health authority is now utilizing bed-monitoring devices to stop falls and gain insights Rowan DunneDecember 10, 2024
Medical and Pharmaceutical AI lung cancer screening tech developer, Imidex, seeks buyer at Chicago conference Its 'VisiRad XR' X-ray assessment system is FDA-approved and assisted by Google Cloud's Vertex AI platform Rowan DunneDecember 2, 2024